1980
DOI: 10.1021/jm00179a001
|View full text |Cite
|
Sign up to set email alerts
|

Soft drugs. 1. Labile quaternary ammonium salts as soft antimicrobials

Abstract: Strategies for the design of safer drugs are discussed. The various classes of "soft drugs" are designed to avoid undesired metabolic disposition (primarily various oxidative routes, occurring via possible toxic intermediates) and to be metabolized by a predictable manner with controlled rates. As a first example for the "soft analogue" type drugs, a new class of antimicrobial, surface-active quaternary salts of the type RCOOCHR1--N+ comes from X- was developed. These "soft" quaternary salts are isosteric anal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
86
0
1

Year Published

1995
1995
2010
2010

Publication Types

Select...
5
4

Relationship

3
6

Authors

Journals

citations
Cited by 153 publications
(87 citation statements)
references
References 0 publications
0
86
0
1
Order By: Relevance
“…These biologically active compounds are readily degraded into non-toxic and biologically inactive products in vivo, as well as in the environment. The concept of soft antibacterial agents was proposed over 20 years ago (20), and a number have been synthesised and tested both in vitro and in vivo. Thorstein et al (17) synthesised a series of analogues of benzalkonium chloride (BAC) and cetylpyridinium chloride (CPC), which showed satisfactory antibacterial properties and were characterised by good chemical stability and ready non-enzymatic and enzymatic degradation to original, non-toxic building blocks.…”
Section: Cationic Surfactantsmentioning
confidence: 99%
“…These biologically active compounds are readily degraded into non-toxic and biologically inactive products in vivo, as well as in the environment. The concept of soft antibacterial agents was proposed over 20 years ago (20), and a number have been synthesised and tested both in vitro and in vivo. Thorstein et al (17) synthesised a series of analogues of benzalkonium chloride (BAC) and cetylpyridinium chloride (CPC), which showed satisfactory antibacterial properties and were characterised by good chemical stability and ready non-enzymatic and enzymatic degradation to original, non-toxic building blocks.…”
Section: Cationic Surfactantsmentioning
confidence: 99%
“…The hydrolysis step should preferably lead not only to a nonactive compound but also to degradation products that are significantly less toxic than the original substance. Compounds based on this type of concept were originally developed by Bodor et al (2) and were introduced as ''soft'' drugs. Soft drugs are defined as biologically active, therapeutically useful compounds characterized by a controllable degradation to nontoxic moieties after they achieve their therapeutic effect.…”
mentioning
confidence: 99%
“…Soft drugs are defined as biologically active, therapeutically useful compounds characterized by a controllable degradation to nontoxic moieties after they achieve their therapeutic effect. This concept can be applied to limit the toxicities of antimicrobial agents, and the first soft drug to be introduced was actually an antimicrobial agent (2).…”
mentioning
confidence: 99%
“…One of the most recent approaches to produce an effective but safe drug is the so-called retrometabolic drug design. Retrometabolically designed drug candidates have already been under investigation in widely different pharmacological fields intended to use as antiglaucoma agents (Bodor, 1989), antimicrobials (Bodor et al, 1980a), antitumor compounds (Bodor and Kaminski, 1980), or as short-acting anticholinergics (Bodor et al, 1980b). As the site of intended action and the site of administration coincide in inhalation therapy, the potential for the application of the retrometabolic approach in the treatment of asthma with ICS is especially promising.…”
Section: Discussionmentioning
confidence: 99%